Matt has been a healthcare-focused venture capital investor since 1980. He began his venture capital career with Citicorp Venture Capital, where he was VP and a member of the investment executive committee. Matt later joined Robertson, Stephens & Co. and was partner and Chairman of the Venture Capital Group. In 1991 he formed Mackowski & Shepler, an investment partnership focused on developing life science and medical technology companies and the predecessor to THP. Matt has represented THP on the boards of Kinetikos Medical (acquired by Integra), Ambion (acquired by Applied Biosystems), Aurora Discovery (acquired by NEXUS Biosystems), Interface Associates, Asuragen, Althea Technologies (acquired by Ajinomoto), AltheaDx, MedPricer and Magstim. Matt received a BA from Duke University and an MBA from The Wharton School.